With the actual site preparation work already under way behind them, the board of Xhale Inc. ceremoniously broke ground Tuesday at SW 47th Avenue off SW 34th Street behind the main post office.
Xhale is developing hand-held devices that can immediately diagnose compounds or pharmaceutical levels in patients' breath, an alternative to blood or urine samples.
CEO Richard Allen said Xhale's building will be ready next spring or summer, about the time he is expecting approval from the Food and Drug Administration to start producing and distributing some products for market.